Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

703
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
703
Inflammation01:38

Inflammation

52.0K
Overview
52.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease.

Frontiers in bioscience (Landmark edition)·2026
Same author

The role of macrophage senescence in cardiovascular diseases.

Cellular signalling·2026
Same author

Qishen Yiqi Formula Mitigates Heart Failure by Restoring Myocardial Energy Metabolism via AMPK: Insights from Multi-Omics Analysis.

Current pharmaceutical design·2026
Same author

TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome.

Frontiers in immunology·2026
Same author

Hypoglycemic Effects of <i>Glehniae Radix</i> Polysaccharides in Female <i>db</i>/<i>db</i> Mice via Modulation of the Gut Microbiota-PPAR Signaling Axis.

Molecules (Basel, Switzerland)·2026
Same author

Qishen Yiqi Dropping Pills ameliorate acute myocardial infarction by modulating PKM2/STAT3 pathway-mediated metabolic reprogramming in macrophages.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Related Experiment Video

Updated: May 17, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

2.6K

Th17 Cells in Cardiovascular Disease.

Ke Yang1,2, Qianqian Liu1,2, Aodi Fan1,2

  • 1State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Cell Biochemistry and Function
|April 4, 2025
PubMed
Summary

T helper 17 (Th17) cells and their cytokine IL-17 are linked to cardiovascular diseases. Understanding Th17 signaling in cardiovascular disease offers potential for targeted treatments.

Keywords:
IL‐17Th17cardiovascular diseaseimmunity

More Related Videos

Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.4K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

34.5K

Related Experiment Videos

Last Updated: May 17, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

2.6K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.4K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

34.5K

Area of Science:

  • Immunology
  • Cardiology
  • Molecular Biology

Background:

  • T helper 17 (Th17) cells and their associated cytokine Interleukin-17 (IL-17) have emerged as significant players in the pathogenesis of various cardiovascular diseases.
  • These conditions include atherosclerosis, myocardial infarction, myocarditis, and cardiac arrhythmia, highlighting a potential central role for Th17 cell signaling in cardiovascular pathology.

Purpose of the Study:

  • To provide a comprehensive summary of recent advancements concerning the source, function, and regulation of Th17 cells and IL-17 signaling.
  • To elucidate the specific effects of Th17 signaling pathways in the context of cardiovascular disease development and progression.

Main Methods:

  • Review and synthesis of current scientific literature on Th17 cells and cardiovascular disease.
  • Analysis of research findings related to the biological mechanisms underlying Th17 cell involvement in cardiovascular pathologies.

Main Results:

  • Established strong correlations between Th17 cell activity/IL-17 and multiple cardiovascular diseases.
  • Identified Th17 cell signaling as a critical factor influencing cardiovascular disease progression.
  • Detailed the multifaceted roles of Th17 cells, including their origins, functions, and regulatory mechanisms in the cardiovascular system.

Conclusions:

  • Further research into Th17 cell biology and signaling pathways is crucial for developing targeted therapeutic strategies.
  • Manipulating Th17 cell functions holds promise for effective treatment and improved clinical outcomes in cardiovascular disease patients.